Laviana Overview

Founded 2005
Status Private
Employees 160
Latest Deal Type Series B1
Latest Deal Amount $14.3M
Latest Deal Amount
Investors 7

Laviana General Information


Provider of a pharmaceutical industrialization outsourcing service intended to innovate medicine research and development process. The company's services include innovative medicine transformation from laboratory to industrial process, market based drug process research and optimization, and provide drugs made by using advanced analytical method development and testing method, enabling physicians to conduct medicine research and development in an efficient manner.

Contact Information

Formerly Known As
Lewei (Taizhou), Laviana (Taizhou) Pharmachem Co., Ltd
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • No.222, Jiming West Road
  • Economic Development Zone
  • Jiangyan, Jiangsu 225500
  • China
+86 0523 0000 0000

Laviana Timeline

Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Laviana Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B1) 26-Aug-2019 $14.3M 0000 Completed Generating Revenue
3. Later Stage VC (Series B) 18-Apr-2018 000.00 000.00 Completed Generating Revenue
2. IPO 29-Aug-2016 $4.86M 00.00 Completed Profitable
1. Later Stage VC (Series A) 28-Mar-2014 $4.86M $4.86M Completed Generating Revenue

Laviana Executive Team (4)

Name Title Board Seat Contact Info
Wenting Chen Chief Executive Officer & Chairman
Hongqing Chen Chief Operating Officer
Guang Yang Chief Scientific Officer
Ling Lu Co-Founder

Laviana Board Members (1)

Name Representing Role Since
Wenting Chen Laviana Chief Executive Officer & Chairman 000 0000

Laviana Investors (7)

To view Laviana‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CMW Asset Management Venture Capital Minority 000 0000 000000 0
Yicun Capital Venture Capital Minority 000 0000 000000 0
ABC Capital Venture Capital Minority 000 0000 000000 0
Crystal Pharmatech VC-Backed Company Minority 000 0000 000000 0
Huayi Capital Other Minority 000 0000 000000 0

Ready to get started?

Request a free trial